irinotecan has been researched along with Benign Cerebellar Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Chen, Z; Tian, F | 1 |
| Benkimoun, I; Chabi, S; Druillennec, S; Eberhart, CG; Findlay, TH; Fujii, Y; Gabdulkhaev, R; Hawkins, E; Imai, C; Imamura, M; Kakita, A; Malebranche, K; Miyahara, H; Miyashita, S; Murai, J; Nakano, T; Nakata, S; Natsumeda, M; Nobusawa, S; Oishi, M; Okada, M; On, J; Osuka, S; Parthasarathy, A; Pommier, Y; Pouponnot, C; Raabe, EH; Rodriguez, FJ; Saito, T; Sasaki, AT; Takahashi, H; Takeshima, H; Tateishi, K; Tsukamoto, Y; Varlet, P; Watanabe, J; Yamada, S; Yamamoto, T; Yamashita, S; Yoshimura, J | 1 |
| Cole, KA; Fox, E; Ijaz, H; Liu, X; Maris, JM; Minard, CG; Reid, JM; Santi, M; Surrey, LF; Voss, S; Weigel, BJ | 1 |
| Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E | 1 |
| Aerts, I; Bailey, S; Breazna, A; Cañete, A; Cisar, L; de Toledo Codina, JS; Dorman, A; Estlin, E; Geoerger, B; Gesner, L; Grill, J; Grundy, RG; Hargrave, D; Leblond, P; Madero, L; Nicolin, G; Perek, D; Verlooy, J | 1 |
| Battiste, JD; Bonney, PA; Maurer, AJ; McNall-Knapp, RY; Santucci, JA; Sughrue, ME | 1 |
| Grigull, L; Hartmann, C; Linderkamp, C; Reinhardt, D; Sander, A; Schmid, H; Weinel, P; Welte, K | 1 |
| Choi, SA; Jin, X; Kim, H; Kim, SK; Kim, SU; Lee, DH; Lee, HJ; Lee, JY; Lim, I; Lim, SH; Phi, JH; Song, JH; Song, SH; Wang, KC | 1 |
| Aboody, KS; Abramyants, Y; Annala, AJ; Barish, ME; Blanchard, MS; D'Apuzzo, M; Gutova, M; Herrmann, KA; Khankaldyyan, V; Kim, SU; Mittelholtz, K; Moats, RA; Najbauer, J; Shackleford, GM; Shi, XH; Synold, TW | 1 |
| Bucci, F; Cusano, G; Di Francesco, AM; Meco, D; Patriarca, V; Pierri, F; Pisano, C; Riccardi, R; Torella, AR | 1 |
| Asai, J; Fujimoto, T; Miyo, T; Nagashima, G; Suzuki, R | 1 |
3 trial(s) available for irinotecan and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Cost-Effectiveness Analysis of a Three-Drug Regimen Containing Bevacizumab for the Treatment of Recurrent Pediatric
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Cerebellar Neoplasms; Child; Cost-Benefit Analysis; Humans; Irinotecan; Medulloblastoma; Temozolomide | 2022 |
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Proteins; Cerebellar Neoplasms; Child; Humans; Irinotecan; Medulloblastoma; Neuroblastoma; Protein-Tyrosine Kinases; Rhabdomyosarcoma | 2023 |
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Dacarbazine; Female; Humans; Irinotecan; Male; Medulloblastoma; Temozolomide | 2013 |
8 other study(ies) available for irinotecan and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Epigenetic upregulation of Schlafen11 renders
WNT- and SHH-activated medulloblastomas sensitive to cisplatin.
Topics: Cerebellar Neoplasms; Cisplatin; Epigenesis, Genetic; Hedgehog Proteins; Humans; Irinotecan; Medulloblastoma; Nuclear Proteins; Up-Regulation | 2023 |
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult | 2013 |
Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Camptothecin; Cerebellar Neoplasms; Dacarbazine; Female; Humans; Irinotecan; Medulloblastoma; Temozolomide; Young Adult | 2016 |
Oxaliplatin, irinotecan, and gemcitabine: a novel combination in the therapy of progressed, relapsed, or refractory tumors in children.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Neuroendocrine; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroblastoma; Organoplatinum Compounds; Osteosarcoma; Oxaliplatin; Retrospective Studies; Treatment Outcome | 2011 |
Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase.
Topics: Animals; Camptothecin; Carboxylesterase; Cerebellar Neoplasms; Genetic Therapy; Humans; Irinotecan; Male; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neural Stem Cells; Prognosis; Rabbits; Random Allocation; Xenograft Model Antitumor Assays | 2011 |
Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carboxylesterase; Cell Line, Tumor; Cerebellar Neoplasms; Gene Transfer Techniques; Genetic Therapy; Humans; Irinotecan; Medulloblastoma; Mice; Mice, Nude; Mice, Transgenic; Neural Stem Cells; Prodrugs; Stem Cell Transplantation; Treatment Outcome | 2013 |
Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Camptothecin; Cell Cycle; Cell Line, Tumor; Cerebellar Neoplasms; Child; Comet Assay; DNA Damage; Drug Synergism; Humans; Irinotecan; Medulloblastoma; Mice; Mice, Nude; Neuroblastoma; Neuroectodermal Tumors, Primitive; Platinum Compounds; Xenograft Model Antitumor Assays | 2012 |
[Irinotecan (topoisomerase-I inhibitor) for the treatment of recurrent primary intracranial malignant lymphoma].
Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Cerebellar Neoplasms; Cranial Irradiation; Humans; Irinotecan; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local | 2000 |